Reported 8 days ago
1789 Capital, led by Omeed Malik and recently employing Donald Trump Jr., has spearheaded a $140 million funding round for the drug startup BlinkRx, which aims to provide affordable prescription medications. The round values BlinkRx at approximately $2 billion, with additional investments from firms like Fidelity Investments and 8VC. 1789 Capital focuses on conservative investments, favoring companies that challenge regulatory barriers in industries like healthcare and education, distancing itself from traditional environmental and social governance principles.
Source: YAHOO